Stockholders' Equity (Details Narrative) - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2019 |
Dec. 31, 2018 |
|
| Preferred stock, shares outstanding | ||
| Series B Convertible Preferred Stock [Member] | ||
| Preferred stock, shares outstanding | ||
| Series E Convertible Preferred Stock [Member] | ||
| Preferred stock, shares outstanding | ||
| Warrant [Member] | ||
| Number of warrant to purchase shares of common stock | 182,191 | |
| Warrants weighted average remaining life | 2 years 9 months 18 days | |
| Weighted average exercise price | $ 25.04 |
| X | ||||||||||
- Definition Weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|